Neoprobe Corporation (OTC BB: NEOP) has focused their efforts on developing and commercializing novel biomedical products that address the critical intraoperative, diagnostic and therapeutic treatment needs of patients and physicians. The company’s main area of dedication is on improving cancer surgery outcomes by utilizing their market-leading gamma detection devices in conjunction with radiopharmaceutical agents.
- 18 years ago
QualityStocks
Neoprobe Corporation (OTC BB: NGNM)
Tags Rodman & Renshaw
Related Post
-
Metalsource Mining Inc. (CSE: MSM) (OTCQB: MSMMF) (FSE: E9Z) Extends Silver Hill Drilling South as It Prepares for Larger Exploration Tests
Disseminated on behalf of Metalsource Mining Inc. and may include paid advertising. Metalsource Mining, advancing…
-
As Major Gold Discoveries Become Scarcer, Lahontan Gold Advances a Past-Producing Nevada Asset
Disseminated on behalf of Lahontan Gold Corp. and may include paid advertising. A shrinking pipeline…
-
Military Drone Spending Is Surging into Airspace Where GPS Can No Longer Be Trusted
Disseminated on behalf of SPARC AI Inc. and may include paid advertising. The Pentagon’s fiscal…